Loading…
Photodynamic therapy using silicon phthalocyanine conjugated with bovine serum albumin as a drug delivery system
In the present study, we describe a new silicon phthalocyanine conjugated to bovine serum albumin (PcSiN3M-BSA) and its photodynamic activity in murine macrophages cells (J774.A1). The nonconjugated precursor, bis(trimethylaminoethanoxy)–phthalocyaninato silicon (IV) (PcSiN3M), was also studied. Com...
Saved in:
Published in: | Laser physics 2021-06, Vol.31 (7), p.75601 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c241t-7358b069b11ccb0b774273300abbd0b8bedaf59a3ff355142be41a5b691d4a433 |
---|---|
cites | cdi_FETCH-LOGICAL-c241t-7358b069b11ccb0b774273300abbd0b8bedaf59a3ff355142be41a5b691d4a433 |
container_end_page | |
container_issue | 7 |
container_start_page | 75601 |
container_title | Laser physics |
container_volume | 31 |
creator | Silva, E P O Ribeiro, N M Cardoso, M A G Pacheco-Soares, C Jr, M Beltrame |
description | In the present study, we describe a new silicon phthalocyanine conjugated to bovine serum albumin (PcSiN3M-BSA) and its photodynamic activity in murine macrophages cells (J774.A1). The nonconjugated precursor, bis(trimethylaminoethanoxy)–phthalocyaninato silicon (IV) (PcSiN3M), was also studied. Compounds PcSiN3M and PcSiN3M-BSA showed no cytotoxicity in the dark, but exhibited high photodynamic activities following exposure to 5
µ
M photosensitizers and 45 J cm
−2
irradiation. These conditions were sufficient to decrease the cell viability to 40% and 5% in cells treated with PcSiN3M and PcSiN3M-BSA, respectively. These results demonstrated an increase of 87% in the photodynamic activity of PcSiN3M when conjugated with BSA. The results shown in this work suggest that PcSiN3M-BSA had higher uptake by J774.A1 cells, which contributed to its higher photoactivity compared with the unconjugated form, PcSiN3N. |
doi_str_mv | 10.1088/1555-6611/abfe58 |
format | article |
fullrecord | <record><control><sourceid>iop_cross</sourceid><recordid>TN_cdi_iop_journals_10_1088_1555_6611_abfe58</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>lpabfe58</sourcerecordid><originalsourceid>FETCH-LOGICAL-c241t-7358b069b11ccb0b774273300abbd0b8bedaf59a3ff355142be41a5b691d4a433</originalsourceid><addsrcrecordid>eNp9kM1LxDAUxIMouK7ePebkyXVfNknbPcriFyzoQcFbeGnSbZa2KUm70v_elhVP4ukNw8zw-BFyzeCOQZYtmZRykSSMLVEXVmYnZPZrnY4apBg1fJ6Tixj3AEIIYDPSvpW-82ZosHY57UobsB1oH12zo9FVLvcNbcuuxMrnAzausXS09v0OO2vol-tKqv1hsqMNfU2x0n3tGoqRIjWh31FjK3ewYaBxiJ2tL8lZgVW0Vz93Tj4eH943z4vt69PL5n67yFeCdYuUy0xDstaM5bkGnaZilXIOgFob0Jm2Bgu5Rl4UXEomVtoKhlIna2YECs7nBI67efAxBluoNrgaw6AYqImYmvCoCY86Ehsrt8eK863a-z4044P_xW_-iFet4kylClKZAFOtKfg3mcp9XA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Photodynamic therapy using silicon phthalocyanine conjugated with bovine serum albumin as a drug delivery system</title><source>Institute of Physics:Jisc Collections:IOP Publishing Read and Publish 2024-2025 (Reading List)</source><creator>Silva, E P O ; Ribeiro, N M ; Cardoso, M A G ; Pacheco-Soares, C ; Jr, M Beltrame</creator><creatorcontrib>Silva, E P O ; Ribeiro, N M ; Cardoso, M A G ; Pacheco-Soares, C ; Jr, M Beltrame</creatorcontrib><description>In the present study, we describe a new silicon phthalocyanine conjugated to bovine serum albumin (PcSiN3M-BSA) and its photodynamic activity in murine macrophages cells (J774.A1). The nonconjugated precursor, bis(trimethylaminoethanoxy)–phthalocyaninato silicon (IV) (PcSiN3M), was also studied. Compounds PcSiN3M and PcSiN3M-BSA showed no cytotoxicity in the dark, but exhibited high photodynamic activities following exposure to 5
µ
M photosensitizers and 45 J cm
−2
irradiation. These conditions were sufficient to decrease the cell viability to 40% and 5% in cells treated with PcSiN3M and PcSiN3M-BSA, respectively. These results demonstrated an increase of 87% in the photodynamic activity of PcSiN3M when conjugated with BSA. The results shown in this work suggest that PcSiN3M-BSA had higher uptake by J774.A1 cells, which contributed to its higher photoactivity compared with the unconjugated form, PcSiN3N.</description><identifier>ISSN: 1054-660X</identifier><identifier>EISSN: 1555-6611</identifier><identifier>DOI: 10.1088/1555-6611/abfe58</identifier><identifier>CODEN: LAPHEJ</identifier><language>eng</language><publisher>IOP Publishing</publisher><subject>bovine serum albumin (BSA) ; murine macrophages cells (J774.A1) ; photodynamic therapy (PDT) ; phthalocyanines</subject><ispartof>Laser physics, 2021-06, Vol.31 (7), p.75601</ispartof><rights>2021 Astro Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c241t-7358b069b11ccb0b774273300abbd0b8bedaf59a3ff355142be41a5b691d4a433</citedby><cites>FETCH-LOGICAL-c241t-7358b069b11ccb0b774273300abbd0b8bedaf59a3ff355142be41a5b691d4a433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Silva, E P O</creatorcontrib><creatorcontrib>Ribeiro, N M</creatorcontrib><creatorcontrib>Cardoso, M A G</creatorcontrib><creatorcontrib>Pacheco-Soares, C</creatorcontrib><creatorcontrib>Jr, M Beltrame</creatorcontrib><title>Photodynamic therapy using silicon phthalocyanine conjugated with bovine serum albumin as a drug delivery system</title><title>Laser physics</title><addtitle>LP</addtitle><addtitle>Laser Phys</addtitle><description>In the present study, we describe a new silicon phthalocyanine conjugated to bovine serum albumin (PcSiN3M-BSA) and its photodynamic activity in murine macrophages cells (J774.A1). The nonconjugated precursor, bis(trimethylaminoethanoxy)–phthalocyaninato silicon (IV) (PcSiN3M), was also studied. Compounds PcSiN3M and PcSiN3M-BSA showed no cytotoxicity in the dark, but exhibited high photodynamic activities following exposure to 5
µ
M photosensitizers and 45 J cm
−2
irradiation. These conditions were sufficient to decrease the cell viability to 40% and 5% in cells treated with PcSiN3M and PcSiN3M-BSA, respectively. These results demonstrated an increase of 87% in the photodynamic activity of PcSiN3M when conjugated with BSA. The results shown in this work suggest that PcSiN3M-BSA had higher uptake by J774.A1 cells, which contributed to its higher photoactivity compared with the unconjugated form, PcSiN3N.</description><subject>bovine serum albumin (BSA)</subject><subject>murine macrophages cells (J774.A1)</subject><subject>photodynamic therapy (PDT)</subject><subject>phthalocyanines</subject><issn>1054-660X</issn><issn>1555-6611</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kM1LxDAUxIMouK7ePebkyXVfNknbPcriFyzoQcFbeGnSbZa2KUm70v_elhVP4ukNw8zw-BFyzeCOQZYtmZRykSSMLVEXVmYnZPZrnY4apBg1fJ6Tixj3AEIIYDPSvpW-82ZosHY57UobsB1oH12zo9FVLvcNbcuuxMrnAzausXS09v0OO2vol-tKqv1hsqMNfU2x0n3tGoqRIjWh31FjK3ewYaBxiJ2tL8lZgVW0Vz93Tj4eH943z4vt69PL5n67yFeCdYuUy0xDstaM5bkGnaZilXIOgFob0Jm2Bgu5Rl4UXEomVtoKhlIna2YECs7nBI67efAxBluoNrgaw6AYqImYmvCoCY86Ehsrt8eK863a-z4044P_xW_-iFet4kylClKZAFOtKfg3mcp9XA</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Silva, E P O</creator><creator>Ribeiro, N M</creator><creator>Cardoso, M A G</creator><creator>Pacheco-Soares, C</creator><creator>Jr, M Beltrame</creator><general>IOP Publishing</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20210601</creationdate><title>Photodynamic therapy using silicon phthalocyanine conjugated with bovine serum albumin as a drug delivery system</title><author>Silva, E P O ; Ribeiro, N M ; Cardoso, M A G ; Pacheco-Soares, C ; Jr, M Beltrame</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c241t-7358b069b11ccb0b774273300abbd0b8bedaf59a3ff355142be41a5b691d4a433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>bovine serum albumin (BSA)</topic><topic>murine macrophages cells (J774.A1)</topic><topic>photodynamic therapy (PDT)</topic><topic>phthalocyanines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silva, E P O</creatorcontrib><creatorcontrib>Ribeiro, N M</creatorcontrib><creatorcontrib>Cardoso, M A G</creatorcontrib><creatorcontrib>Pacheco-Soares, C</creatorcontrib><creatorcontrib>Jr, M Beltrame</creatorcontrib><collection>CrossRef</collection><jtitle>Laser physics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silva, E P O</au><au>Ribeiro, N M</au><au>Cardoso, M A G</au><au>Pacheco-Soares, C</au><au>Jr, M Beltrame</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Photodynamic therapy using silicon phthalocyanine conjugated with bovine serum albumin as a drug delivery system</atitle><jtitle>Laser physics</jtitle><stitle>LP</stitle><addtitle>Laser Phys</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>31</volume><issue>7</issue><spage>75601</spage><pages>75601-</pages><issn>1054-660X</issn><eissn>1555-6611</eissn><coden>LAPHEJ</coden><abstract>In the present study, we describe a new silicon phthalocyanine conjugated to bovine serum albumin (PcSiN3M-BSA) and its photodynamic activity in murine macrophages cells (J774.A1). The nonconjugated precursor, bis(trimethylaminoethanoxy)–phthalocyaninato silicon (IV) (PcSiN3M), was also studied. Compounds PcSiN3M and PcSiN3M-BSA showed no cytotoxicity in the dark, but exhibited high photodynamic activities following exposure to 5
µ
M photosensitizers and 45 J cm
−2
irradiation. These conditions were sufficient to decrease the cell viability to 40% and 5% in cells treated with PcSiN3M and PcSiN3M-BSA, respectively. These results demonstrated an increase of 87% in the photodynamic activity of PcSiN3M when conjugated with BSA. The results shown in this work suggest that PcSiN3M-BSA had higher uptake by J774.A1 cells, which contributed to its higher photoactivity compared with the unconjugated form, PcSiN3N.</abstract><pub>IOP Publishing</pub><doi>10.1088/1555-6611/abfe58</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1054-660X |
ispartof | Laser physics, 2021-06, Vol.31 (7), p.75601 |
issn | 1054-660X 1555-6611 |
language | eng |
recordid | cdi_iop_journals_10_1088_1555_6611_abfe58 |
source | Institute of Physics:Jisc Collections:IOP Publishing Read and Publish 2024-2025 (Reading List) |
subjects | bovine serum albumin (BSA) murine macrophages cells (J774.A1) photodynamic therapy (PDT) phthalocyanines |
title | Photodynamic therapy using silicon phthalocyanine conjugated with bovine serum albumin as a drug delivery system |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T13%3A10%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-iop_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Photodynamic%20therapy%20using%20silicon%20phthalocyanine%20conjugated%20with%20bovine%20serum%20albumin%20as%20a%20drug%20delivery%20system&rft.jtitle=Laser%20physics&rft.au=Silva,%20E%20P%20O&rft.date=2021-06-01&rft.volume=31&rft.issue=7&rft.spage=75601&rft.pages=75601-&rft.issn=1054-660X&rft.eissn=1555-6611&rft.coden=LAPHEJ&rft_id=info:doi/10.1088/1555-6611/abfe58&rft_dat=%3Ciop_cross%3Elpabfe58%3C/iop_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c241t-7358b069b11ccb0b774273300abbd0b8bedaf59a3ff355142be41a5b691d4a433%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |